PharmTech spoke with Ian Bilodeau, managing director, Ardena US about how the expanded use of AI has impacted the ...

Supply chains are being diversified and regionalized to mitigate global disruptions, with significant investments in US ...

In late December 2025, Charles Ross & Son promoted its five-cubic-foot double cone tumbler blender for small- to mid-scale ...

Remco Munnik, Arcana, details pharma's shift to data-first operations, AI adoption, and robust data stewardship.

The third and final portion of Bryant’s exclusive video interview with PharmTech ® deals with the processes known as human-in ...

Digital GMP expectations are increasing, driven by Annex 11 and Annex 22, necessitating robust lifecycle management, data ...

Our data show that global pharma M&A is becoming more selective and strategically targeted. While North America remains the ...

Next-generation biologics, such as bispecifics, fusion proteins, and multi-specifics, have multiple functionalities that ...

In an expansion of his written three-part series for PharmTech, Jason Bryant of ArisGlobal explains the interplay between ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

André Cerbe, CEO of Schlafender Hase, spoke with Pharmaceutical Technology® about the disruptions the pharma industry faced ...

From a global regulatory perspective, Cytokinetics is expanding its footprint rapidly. The drug received approval in China on ...